Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,048 | 9,264 | 30,804 | 13,254 | 16,548 |
| Marketable Securities | 8,340 | 29,088 | 8,675 | 27,733 | 25,289 |
| Receivables | 751 | 1,421 | 1,189 | 1,607 | 1,836 |
| Inventories | 776 | 841 | 924 | 988 | 1,087 |
| Other current assets | 664 | 521 | 362 | 96 | 59 |
| TOTAL | $40,579 | $41,136 | $41,954 | $43,678 | $44,819 |
| Non-Current Assets | |||||
| PPE Net | 10,465 | 10,013 | 8,606 | 7,535 | 7,046 |
| Other Non-Current Assets | 352 | 437 | 610 | 854 | 855 |
| TOTAL | $10,817 | $10,450 | $9,216 | $8,389 | $7,900 |
| Total Assets | $48,024 | $48,384 | $48,128 | $49,186 | $50,015 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 744 | 868 | 605 | 337 | 851 |
| Accrued Expenses | 382 | 375 | 437 | 338 | 523 |
| TOTAL | $1,126 | $1,243 | $1,042 | $675 | $1,374 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,126 | $1,243 | $1,042 | $675 | $1,374 |
| Shareholders' Equity | |||||
| Common Shares | 66 | 67 | 67 | 68 | 68 |
| Retained earnings | 2,262 | 2,268 | 2,217 | 2,003 | 2,263 |
| Other shareholders' equity | -1 | 0 | 1 | 0 | 0 |
| TOTAL | $46,898 | $47,141 | $47,086 | $48,511 | $48,642 |
| Total Liabilities And Equity | $48,024 | $48,384 | $48,128 | $49,186 | $50,016 |